Overview

An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety and/or efficacy of rosiglitazone/metformin administered in Korean Diabetic patients according to the prescribing information
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Metformin
Rosiglitazone